Open access
Jul 2026
Clinical Implications of CD19‐Negative Relapse Following CD19‐Directed Therapy in B‐Cell Acute Lymphoblastic Leukemia
Patients with ALL who develop CD19‐relapse after CD19‐directed therapy have poor outcomes and limited therapeutic options.
T. Othman, Vaibhav Agrawal, Joo Y. Song et al.
· American journal of hematolo... · 0 citations